myeloproliferative neoplasm therapeutics (Syros)

N/A

Report date: 2025/03/20 15:25:46
NME

Base Information

Drug Namemyeloproliferative neoplasm therapeutics (Syros)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMyeloproliferative Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSyros Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesSyros Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsMyeloproliferative Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A